Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP501490.RAr2oztsAPdKWsrwuWRPYCH11q8vLqi-bGsc_GpexbDgU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP501490.RAr2oztsAPdKWsrwuWRPYCH11q8vLqi-bGsc_GpexbDgU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP501490.RAr2oztsAPdKWsrwuWRPYCH11q8vLqi-bGsc_GpexbDgU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP501490.RAr2oztsAPdKWsrwuWRPYCH11q8vLqi-bGsc_GpexbDgU130_provenance.
- NP501490.RAr2oztsAPdKWsrwuWRPYCH11q8vLqi-bGsc_GpexbDgU130_assertion description "[Histologic sections of formalin-fixed, paraffin-embedded specimens from 11 patients with benign serous or mucinous cystadenomas, 14 patients with serous or mucinous borderline tumors, and 80 patients with epithelial-ovarian adenocarcinomas (29 serous, 17 endometrioid, 14 mucinous, and 20 clear cell adenocarcinomas) were stained for P-LAP and GLUT4 using each polyclonal antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501490.RAr2oztsAPdKWsrwuWRPYCH11q8vLqi-bGsc_GpexbDgU130_provenance.
- NP501490.RAr2oztsAPdKWsrwuWRPYCH11q8vLqi-bGsc_GpexbDgU130_assertion evidence source_evidence_literature NP501490.RAr2oztsAPdKWsrwuWRPYCH11q8vLqi-bGsc_GpexbDgU130_provenance.
- NP501490.RAr2oztsAPdKWsrwuWRPYCH11q8vLqi-bGsc_GpexbDgU130_assertion SIO_000772 15907336 NP501490.RAr2oztsAPdKWsrwuWRPYCH11q8vLqi-bGsc_GpexbDgU130_provenance.
- NP501490.RAr2oztsAPdKWsrwuWRPYCH11q8vLqi-bGsc_GpexbDgU130_assertion wasDerivedFrom befree-20140225 NP501490.RAr2oztsAPdKWsrwuWRPYCH11q8vLqi-bGsc_GpexbDgU130_provenance.
- NP501490.RAr2oztsAPdKWsrwuWRPYCH11q8vLqi-bGsc_GpexbDgU130_assertion wasGeneratedBy ECO_0000203 NP501490.RAr2oztsAPdKWsrwuWRPYCH11q8vLqi-bGsc_GpexbDgU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP501490.RAr2oztsAPdKWsrwuWRPYCH11q8vLqi-bGsc_GpexbDgU130_provenance.